Febrile neutropenia: Clinical sciences

1,406views

Febrile neutropenia: Clinical sciences

Core Conditions

Core Conditions

Plasmodium species (Malaria)
Antimalarials
HIV and AIDS: Pathology review
Testicular cancer
Testicular and scrotal conditions: Pathology review
Testicular tumors: Pathology review
Colorectal cancer
Colorectal cancer: Clinical
Colorectal cancer: Clinical sciences
Colorectal polyps and cancer: Pathology review
Colorectal cancer screening: Clinical sciences
Heart failure
Heart failure: Pathology review
Chronic kidney disease: Clinical sciences
Acute coronary syndrome: Clinical sciences
Angina pectoris
Atrial fibrillation
Ventricular tachycardia
Heart blocks: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Multiple sclerosis
Demyelinating disorders: Pathology review
Ascending and descending spinal tracts
Personality disorders: Pathology review
Schizophrenia spectrum disorders: Pathology review
Typical antipsychotics
Atypical antipsychotics
Psychiatric emergencies: Pathology review
Back pain: Pathology review
Anatomy clinical correlates: Bones, joints and muscles of the back
Osteoporosis
Osteoporosis: Clinical sciences
Osteoporosis medications
Bones of the vertebral column
Lordosis, kyphosis, and scoliosis
Vessels and nerves of the vertebral column
Muscles of the back
Cauda equina syndrome
Blood groups and transfusions
Blood products and transfusion: Clinical
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Preeclampsia & eclampsia
Aortic dissections and aneurysms: Pathology review
Aortic dissection
Aortic aneurysms and dissections: Clinical
Aortic dissection: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Leukemias: Pathology review
Acute leukemia
Complement system
Immune thrombocytopenia
Heparin-induced thrombocytopenia
Thrombotic thrombocytopenic purpura
Essential thrombocythemia (NORD)
Systemic lupus erythematosus
Systemic lupus erythematosus: Clinical sciences
Antiphospholipid syndrome
Treponema pallidum (Syphilis)
Fever of unknown origin: Clinical
Oral cancer
Anal cancer: Clinical sciences
Thyroid cancer
Gastric cancer
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis
Autoimmune hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Alcohol-induced hepatitis: Clinical sciences
Hepatitis C: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis A and E: Clinical sciences
Viral hepatitis: Clinical
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Cushing syndrome
Graves disease
Chronic leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Stroke: Clinical
Ischemic stroke
Subarachnoid hemorrhage
Intracerebral hemorrhage
Gallbladder disorders: Pathology review
Approach to biliary colic: Clinical sciences
Biliary colic
Gallstone ileus
Anaphylaxis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Malaria: Clinical sciences
Sepsis: Clinical sciences
Approach to shock: Clinical sciences
Polymyalgia rheumatica
Rheumatoid arthritis
Measles virus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyponatremia
Electrolyte disturbances: Pathology review
Hyperkalemia
Hypercalcemia
Hypokalemia
Hypernatremia
Vasculitis: Pathology review
Vasculitis
Lymphomas: Pathology review
Myelodysplastic syndromes
Polycythemia vera (NORD)
Pulmonary transfusion reactions: Clinical sciences
Kawasaki disease
Upper respiratory tract infection
Febrile neutropenia: Clinical sciences
Severe chronic neutropenia (NORD)
Approach to postoperative respiratory distress: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Atelectasis: Clinical sciences
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Cystic fibrosis
Cystic fibrosis: Pathology review
Dyslipidemias: Pathology review
Hyperthyroidism
Hypothyroidism: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism
Laryngitis
Nasal polyps
Diabetes insipidus and SIADH: Pathology review

Decision-Making Tree

Transcript

Watch video only

Febrile neutropenia is defined as either a single oral temperature of 101 degrees Fahrenheit or 100.4 degrees lasting an hour or more, both in the setting of an absolute neutrophil count or ANC lower than 1500 cells per microliter, while severe neutropenia is defined as an ANC lower than 500.

Neutropenia is commonly caused by chemotherapy, but it can also result from other medications, autoimmune diseases, or infections. So, whether or not you confirm the source of infection, you can further classify as febrile neutropenia with confirmed infection or fever of unknown origin, or FUO for short.

Now, if you suspect febrile neutropenia, you should first perform an ABCDE assessment to determine if your patient is unstable or stable.

If unstable, stabilize the airway, breathing, and circulation. Next, obtain IV access and consider starting IV fluids. Keep in mind that septic patients with febrile neutropenia may have profound hemodynamic instability requiring urgent volume resuscitation.

In addition, put your patient on continuous vital sign monitoring including blood pressure, heart rate, and pulse oximetry, and provide supplemental oxygen if needed. Finally, don’t forget to start empiric broad-spectrum antibiotics.

Alright, now that we're done with unstable patients, let’s go back to the ABCDE assessment and discuss the stable ones.

If your patient is stable, first obtain a focused history and physical examination. Your patient typically reports fever and malaise, as well as symptoms of infection, like a new onset cough, dysuria, diarrhea, or erythema of the skin. These symptoms usually occur while undergoing chemotherapy, or after starting a medication associated with neutropenia, like carbamazepine or an aminosalicylate.

They may also report a history of a chronic viral infection, like HIV and hepatitis; or an autoimmune disease, such as rheumatoid arthritis or Sjogren syndrome.

On the other hand, physical examination primarily reveals a single oral temperature of 101 degrees Fahrenheit or higher, or a temperature above 100.4 degrees for an hour or more. In other words, a single oral temperature of 38.3o Celsius or higher, or a temperature above 38o Celsius for an hour or more.

You might also find localized signs of infection, like abnormal breath sounds, suprapubic or abdominal tenderness, or warmth and skin induration.

If you notice these findings, you should suspect an infection with neutropenia. Next, order labs, including a CBC with differential, and blood cultures from at least two separate sites. For example, if your patient has a central venous catheter in place, one site should be from the lumen, and the other from a peripheral site.

Depending on the history and physical exam findings, you may also need to order other cultures from urine, stool, CSF, or wound.

Now, here’s a high-yield fact! Do not perform digital rectal examination in patients with suspected or confirmed neutropenia, because of the risk of microtrauma and inadvertent translocation of bacteria into the bloodstream!

Now, before you do anything else, start an IV antipseudomonal beta-lactam antibiotic such as cefepime, a carbapenem, or piperacillin-tazobactam. In fact, the initial dose should be given within the first hour of patient presentation, even if you can’t obtain cultures beforehand.

And here’s one clinical pearl to keep in mind! If your patient has previously been infected or colonized with a resistant organism, or if your hospital has high local resistance rates, consider additional coverage to target resistant pathogens.

Common resistant bacteria include methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus, and extended-spectrum β-lactamase–producing gram-negative bacteria.

Once you start an IV antipseudomonal beta-lactam, calculate your patient’s absolute neutrophil count or ANC for short. This will help you determine if febrile neutropenia is present or not. ANC is determined by multiplying the total WBC count by the percentage of polymorphonuclear and band cells, then dividing this figure by 100.

Sources

  1. "Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update" Journal of Clinical Oncology (2018)
  2. "Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology" Journal of the National Comprehensive Cancer Network (2016)
  3. "Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America" Clinical Infectious Diseases (2011)
  4. "Harrison's Principles of Internal Medicine, 20e." McGraw Hill (2018)
  5. "Approach to fever in patients with neutropenia: a review of diagnosis and management" Therapeutic Advances in Infectious Disease (2022)
  6. "Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer" Cochrane Database of Systematic Reviews (2019)